Can-Fite BioPharma (CANF) Other Accumulated Expenses (2013 - 2026)
Can-Fite BioPharma's Other Accumulated Expenses came in at $1.09 million for Q2 2026, up 115.6% from $506,000 a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Can-Fite BioPharma's Other Accumulated Expenses was $1.11 million, up 13.6% from FY2024.
- Other Accumulated Expenses has increased in each of the last three years, with a five-year compound annual growth rate of 27.4% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $976,000 in FY2024 (+3.4%), $944,000 in FY2023 (+21.8%), $775,000 in FY2022 (-14.4%) and $905,000 in FY2021 (+173.4%).
- The five-year range for quarterly Other Accumulated Expenses is $305,000 (Q3 2021) to $1.11 million (Q4 2025).
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q4 2021 (growth of 173.4%), and the weakest in Q2 2024 (a decline of 27.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Can-Fite BioPharma | 1.79 Mn | -17.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Jun 30, 2025 | 506,000.00 |
| Dec 31, 2024 | 976,000.00 |
| Jun 30, 2024 | 430,000.00 |
| Dec 31, 2023 | 944,000.00 |
| Sep 30, 2023 | 746,000.00 |
| Jun 30, 2023 | 596,000.00 |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 775,000.00 |
| Sep 30, 2022 | 458,000.00 |
| Jun 30, 2022 | 464,000.00 |
| Mar 31, 2022 | 907,000.00 |
| Dec 31, 2021 | 905,000.00 |
| Sep 30, 2021 | 305,000.00 |
| Jun 30, 2021 | 309,000.00 |
| Mar 31, 2021 | 726,000.00 |
| Dec 31, 2020 | 331,000.00 |
| Sep 30, 2020 | 398,000.00 |
| Jun 30, 2020 | 472,000.00 |
API Access
Can-Fite BioPharma Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();